- Walgreens puts its money where its mouth is with World AIDS Day campaign
- UnitedHealth: Cost of diabetes could be $3.35 trillion by 2020
- MMR vaccine, autism link was fabricated, medical journal says
- Walgreens allies with HHS to launch free flu shot outreach to disadvantaged
- Walgreens launches high-impact push in support of World AIDS Day campaign
PITTSBURGH — The Food and Drug Administration has approved a new drug for genital herpes made by Mylan, the drug maker said Wednesday.
Mylan announced the approval of acyclovir ointment in the 5% strength. The drug is a generic version of Valeant International's Zovirax, used to manage initial genital herpes and in limited, non-life-threatening mucocutaneous herpes simplex virus infections in patients with compromised immune systems.
Various versions of the drug had sales of about $230 million in 2012, according to IMS Health. Mylan said it would start shipping the drug immediately.